1. Effectiveness and safety of nab-paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study
   Liangliang Wang et al, 2023, Journal of Gynecologic Oncology CrossRef
2. Update value and clinical application of MUC16 (cancer antigen 125)
   Yaan Song et al, 2023, Expert Opinion on Therapeutic Targets CrossRef
3. Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer
   Szymon Piatek et al, 2021, Scientific Reports CrossRef
4. A novel clinical nomogram for predicting cancer-specific survival in patients with non-serous epithelial ovarian cancer: A real-world analysis based on the Surveillance, Epidemiology, and End Results database and external validation in a tertiary center
   Hui Zheng et al, 2024, Translational Oncology CrossRef
5. A Practical Nomogram to Predict Early Death in Advanced Epithelial Ovarian Cancer
   Zixuan Song et al, 2021, Frontiers in Oncology CrossRef